Pegfilgrastim (Ziextenzo) inj 6 mg per 0.6 ml syringe: Supply issue resolved

Affected product

Due to issues with the packaging of the most recent shipment of Ziextenzo, Sandoz (the supplier) has a supply issue affecting:

Chemical: Pegfilgrastim

• Presentation: Inj 6 mg per 0.6 ml syringe
• Brand: Ziextenzo
• Pharmacode: 2643340 
• Subsidy: $65.00
• Measure / Qty: per 1

Alternative product

Sandoz is bringing in its Australian version of the product. It was listed in the Pharmaceutical Schedule from 20 November 2024.

It is the same product, made in the same place, containing the same ingredients in the same quantities. The only difference is the packaging and labelling. Medsafe has reviewed the product and approved it for sale in New Zealand. 

Chemical: Pegfilgrastim

• Presentation: Inj 6 mg per 0.6 ml syringe
• Brand: Ziextenzo AU
• Pharmacode: 2696045
• Subsidy: $65.00
• Measure / Qty: per 1

It was initially listed as a section 29 medicine but has since been approved by Medsafe. 

We have developed a flier to support conversations with patients about this medicine

Resupplied March 2025

The supplier, Sandoz, has received stock of the New Zealand packaged product. It has been released to wholesalers.  The Australian packaged stock will remain listed for a while to ensure pharmacies can continue to claim for dispensing this product. 

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.

Sign up to our email list for regular emails about supply issues and more(external link)